Dr Ross Porter
- CRUK TRACC Clinical Lecturer (School of Cancer Sciences)
Publications
2025
Grant, R. et al. (2025) Clinical outcomes in frail elderly patients undergoing small-bowel capsule endoscopy. Frontline Gastroenterology, 16(1), pp. 30-36. (doi: 10.1136/flgastro-2024-102746)
2024
Geldof, J. et al. (2024) Prophylactic versus endoscopy-driven treatment of Crohn's postoperative recurrence: a retrospective, multicentric, European study [PORCSE Study]. Journal of Crohn's and Colitis, 18(8), pp. 1202-1214. (doi: 10.1093/ecco-jcc/jjae011) (PMID:38243807)
Baxter, M. et al. (2024) An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma. ESMO Open, 9(5), 103450. (doi: 10.1016/j.esmoop.2024.103450) (PMID:38744099) (PMCID:PMC11108838)
2023
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Din, Shahida, Bankhead, Peter, Oniscu, Anca and Arends, Mark J.
(2023)
QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray.
Diagnostics, 13(11),
1890.
(doi: 10.3390/diagnostics13111890)
(PMID:37296742)
(PMCID:PMC10253133)
Porter, R. J. et al. (2023) Subcellular epithelial HMGB1 expression is associated with colorectal neoplastic progression, male sex, mismatch repair protein expression, lymph node positivity, and an ‘immune cold’ phenotype associated with poor survival. Cancers, 15(6), 1865. (doi: 10.3390/cancers15061865) (PMID:36980751) (PMCID:PMC10047220)
2022
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, McKinlay, Alastair W. and Metcalfe, Emma L.
(2022)
Endoscopically placed venting gastrostomy can be a safe and effective palliative intervention in benign and malignant gastrointestinal obstruction.
Frontline Gastroenterology, 13(4),
pp. 309-315.
(doi: 10.1136/flgastro-2021-101930)
(PMID:35722598)
(PMCID:PMC9186026)
Halliday, Grant, Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Black, Catherine J., Arends, Mark J. and Din, Shahida
(2022)
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions.
World Journal of Gastroenterology, 28(13),
pp. 1338-1346.
(doi: 10.3748/wjg.v28.i13.1338)
(PMID:35645542)
(PMCID:PMC9099184)
Evans, J. A. et al. (2022) Clonal transitions and phenotypic evolution in Barrett’s Esophagus. Gastroenterology, 162(4), 1197-1209.e13. (doi: 10.1053/j.gastro.2021.12.271) (PMID:34973296) (PMCID:PMC8972067)
Brice, Daniel, Murray, Graeme, Wilson, Heather, Porter, Ross ORCID: https://orcid.org/0000-0001-5043-186X, Berry, Susan, Durum, Scott and McLean, Mairi
(2022)
Interleukin-27 regulates the function of the gastrointestinal epithelial barrier in a human tissue-derived organoid model.
Biology, 11(3),
427.
(doi: 10.3390/biology11030427)
(PMID:35336801)
(PMCID:PMC8945023)
2021
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Arends, Mark J,, Churchhouse, Antoniaa M.D. and Din, Shahida
(2021)
Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines.
Journal of Crohn's and Colitis, 15(12),
pp. 2131-2141.
(doi: 10.1093/ecco-jcc/jjab102)
(PMID:34111282)
(PMCID:PMC8684457)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Murray, Graeme I., Alnabulsi, Abdo, Humphries, Matthew P., James, Jacqueline A., Salto-Tellez, Manuel, Craig, Stephanie G., Wang, Ji M., Yoshimura, Teizo and McLean, Mairi H.
(2021)
Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate: LL-37 expression in colorectal cancer.
Journal of Pathology: Clinical Research, 7(5),
pp. 495-506.
(doi: 10.1002/cjp2.222)
(PMID:33988317)
(PMCID:PMC8363930)
Porter, Ross J/ ORCID: https://orcid.org/0000-0001-5043-186X, Smith, Katie J., Ho, Gwo-Tzer and Gwyer Findlay, Emily
(2021)
Immunofluorescence on FFPE tissue sections from inflamed and non-inflamed human gut.
[Protocols]
Squires, Charlotte, Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X and Ward, Benjamin M.
(2021)
Lessons from recent medical history: an obsolete anti-reflux device in an older patient with variable gastrointestinal symptoms.
Age and Ageing, 50(4),
pp. 1426-1427.
(doi: 10.1093/ageing/afab089)
(PMID:34038518)
2020
Porter, Ross ORCID: https://orcid.org/0000-0001-5043-186X, Murray, Graeme I. and McLean, Mairi H.
(2020)
Current concepts in tumour-derived organoids.
British Journal of Cancer, 123,
pp. 1209-1218.
(doi: 10.1038/s41416-020-0993-5)
(PMID:32728094)
(PMCID:PMC7555542)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Kalla, Rahul and Ho, Gwo-Tzer
(2020)
Ulcerative colitis: Recent advances in the understanding of disease pathogenesis.
F1000Research, 9,
294.
(doi: 10.12688/f1000research.20805.1)
(PMID:32399194)
(PMCID:PMC7194476)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Murray, Graeme I., Brice, Daniel P., Petty, Russell D. and McLean, Mairi H.
(2020)
Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype.
British Journal of Cancer, 122,
pp. 545-554.
(doi: 10.1038/s41416-019-0685-1)
(PMID:31831860)
(PMCID:PMC7028982)
2019
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, McKinlay, Alastair W. and Metcalfe, Emma L.
(2019)
Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit.
Frontline Gastroenterology, 11(5),
pp. 364-370.
(doi: 10.1136/flgastro-2019-101306)
(PMID:32884630)
(PMCID:PMC7447287)
2018
Porter, Ross John ORCID: https://orcid.org/0000-0001-5043-186X, Andrews, Caroline, Brice, Daniel Paul, Durum, Scott Kenneth and McLean, Mairi Hall
(2018)
Can we target endogenous anti-inflammatory responses as a therapeutic strategy for inflammatory bowel disease?
Inflammatory Bowel Diseases, 24(10),
pp. 2123-2134.
(doi: 10.1093/ibd/izy230)
(PMID:30020451)
(PMCID:PMC6140439)
Cramer, S. D. et al. (2018) Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia. Leukemia, 32, pp. 1795-1882. (doi: 10.1038/s41375-017-0001-0) (PMID:29535426) (PMCID:PMC7984718)
2015
Steele, C. et al. (2015) CXCR2 inhibition suppresses acute and chronic pancreatic inflammation. Journal of Pathology, 237(1), pp. 85-97. (doi: 10.1002/path.4555) (PMID:25950520)
Articles
Grant, R. et al. (2025) Clinical outcomes in frail elderly patients undergoing small-bowel capsule endoscopy. Frontline Gastroenterology, 16(1), pp. 30-36. (doi: 10.1136/flgastro-2024-102746)
Geldof, J. et al. (2024) Prophylactic versus endoscopy-driven treatment of Crohn's postoperative recurrence: a retrospective, multicentric, European study [PORCSE Study]. Journal of Crohn's and Colitis, 18(8), pp. 1202-1214. (doi: 10.1093/ecco-jcc/jjae011) (PMID:38243807)
Baxter, M. et al. (2024) An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma. ESMO Open, 9(5), 103450. (doi: 10.1016/j.esmoop.2024.103450) (PMID:38744099) (PMCID:PMC11108838)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Din, Shahida, Bankhead, Peter, Oniscu, Anca and Arends, Mark J.
(2023)
QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray.
Diagnostics, 13(11),
1890.
(doi: 10.3390/diagnostics13111890)
(PMID:37296742)
(PMCID:PMC10253133)
Porter, R. J. et al. (2023) Subcellular epithelial HMGB1 expression is associated with colorectal neoplastic progression, male sex, mismatch repair protein expression, lymph node positivity, and an ‘immune cold’ phenotype associated with poor survival. Cancers, 15(6), 1865. (doi: 10.3390/cancers15061865) (PMID:36980751) (PMCID:PMC10047220)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, McKinlay, Alastair W. and Metcalfe, Emma L.
(2022)
Endoscopically placed venting gastrostomy can be a safe and effective palliative intervention in benign and malignant gastrointestinal obstruction.
Frontline Gastroenterology, 13(4),
pp. 309-315.
(doi: 10.1136/flgastro-2021-101930)
(PMID:35722598)
(PMCID:PMC9186026)
Halliday, Grant, Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Black, Catherine J., Arends, Mark J. and Din, Shahida
(2022)
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions.
World Journal of Gastroenterology, 28(13),
pp. 1338-1346.
(doi: 10.3748/wjg.v28.i13.1338)
(PMID:35645542)
(PMCID:PMC9099184)
Evans, J. A. et al. (2022) Clonal transitions and phenotypic evolution in Barrett’s Esophagus. Gastroenterology, 162(4), 1197-1209.e13. (doi: 10.1053/j.gastro.2021.12.271) (PMID:34973296) (PMCID:PMC8972067)
Brice, Daniel, Murray, Graeme, Wilson, Heather, Porter, Ross ORCID: https://orcid.org/0000-0001-5043-186X, Berry, Susan, Durum, Scott and McLean, Mairi
(2022)
Interleukin-27 regulates the function of the gastrointestinal epithelial barrier in a human tissue-derived organoid model.
Biology, 11(3),
427.
(doi: 10.3390/biology11030427)
(PMID:35336801)
(PMCID:PMC8945023)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Arends, Mark J,, Churchhouse, Antoniaa M.D. and Din, Shahida
(2021)
Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines.
Journal of Crohn's and Colitis, 15(12),
pp. 2131-2141.
(doi: 10.1093/ecco-jcc/jjab102)
(PMID:34111282)
(PMCID:PMC8684457)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Murray, Graeme I., Alnabulsi, Abdo, Humphries, Matthew P., James, Jacqueline A., Salto-Tellez, Manuel, Craig, Stephanie G., Wang, Ji M., Yoshimura, Teizo and McLean, Mairi H.
(2021)
Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate: LL-37 expression in colorectal cancer.
Journal of Pathology: Clinical Research, 7(5),
pp. 495-506.
(doi: 10.1002/cjp2.222)
(PMID:33988317)
(PMCID:PMC8363930)
Squires, Charlotte, Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X and Ward, Benjamin M.
(2021)
Lessons from recent medical history: an obsolete anti-reflux device in an older patient with variable gastrointestinal symptoms.
Age and Ageing, 50(4),
pp. 1426-1427.
(doi: 10.1093/ageing/afab089)
(PMID:34038518)
Porter, Ross ORCID: https://orcid.org/0000-0001-5043-186X, Murray, Graeme I. and McLean, Mairi H.
(2020)
Current concepts in tumour-derived organoids.
British Journal of Cancer, 123,
pp. 1209-1218.
(doi: 10.1038/s41416-020-0993-5)
(PMID:32728094)
(PMCID:PMC7555542)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Kalla, Rahul and Ho, Gwo-Tzer
(2020)
Ulcerative colitis: Recent advances in the understanding of disease pathogenesis.
F1000Research, 9,
294.
(doi: 10.12688/f1000research.20805.1)
(PMID:32399194)
(PMCID:PMC7194476)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, Murray, Graeme I., Brice, Daniel P., Petty, Russell D. and McLean, Mairi H.
(2020)
Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype.
British Journal of Cancer, 122,
pp. 545-554.
(doi: 10.1038/s41416-019-0685-1)
(PMID:31831860)
(PMCID:PMC7028982)
Porter, Ross J. ORCID: https://orcid.org/0000-0001-5043-186X, McKinlay, Alastair W. and Metcalfe, Emma L.
(2019)
Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit.
Frontline Gastroenterology, 11(5),
pp. 364-370.
(doi: 10.1136/flgastro-2019-101306)
(PMID:32884630)
(PMCID:PMC7447287)
Porter, Ross John ORCID: https://orcid.org/0000-0001-5043-186X, Andrews, Caroline, Brice, Daniel Paul, Durum, Scott Kenneth and McLean, Mairi Hall
(2018)
Can we target endogenous anti-inflammatory responses as a therapeutic strategy for inflammatory bowel disease?
Inflammatory Bowel Diseases, 24(10),
pp. 2123-2134.
(doi: 10.1093/ibd/izy230)
(PMID:30020451)
(PMCID:PMC6140439)
Cramer, S. D. et al. (2018) Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia. Leukemia, 32, pp. 1795-1882. (doi: 10.1038/s41375-017-0001-0) (PMID:29535426) (PMCID:PMC7984718)
Steele, C. et al. (2015) CXCR2 inhibition suppresses acute and chronic pancreatic inflammation. Journal of Pathology, 237(1), pp. 85-97. (doi: 10.1002/path.4555) (PMID:25950520)
Protocols
Porter, Ross J/ ORCID: https://orcid.org/0000-0001-5043-186X, Smith, Katie J., Ho, Gwo-Tzer and Gwyer Findlay, Emily
(2021)
Immunofluorescence on FFPE tissue sections from inflamed and non-inflamed human gut.
[Protocols]
Prior publications
Article
Ross J Porter et al. (2025) Real-world retrospective cohort study of inflammatory bowel disease colorectal cancer surveillance Frontline Gastroenterology Crossref. (doi: 10.1136/flgastro-2025-103136)